These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 30121626)

  • 1. Prediagnostic circulating markers of inflammation and risk of oesophageal adenocarcinoma: a study within the National Cancer Institute Cohort Consortium.
    Cook MB; Barnett MJ; Bock CH; Cross AJ; Goodman PJ; Goodman GE; Haiman CA; Khaw KT; McCullough ML; Newton CC; Boutron-Ruault MC; Lund E; Rutegård M; Thornquist MD; Spriggs M; Giffen C; Freedman ND; Kemp T; Kroenke CH; Le Marchand L; Park JY; Simon M; Wilkens LR; Pinto L; Hildesheim A; Campbell PT
    Gut; 2019 Jun; 68(6):960-968. PubMed ID: 30121626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating inflammation markers and prospective risk for lung cancer.
    Shiels MS; Pfeiffer RM; Hildesheim A; Engels EA; Kemp TJ; Park JH; Katki HA; Koshiol J; Shelton G; Caporaso NE; Pinto LA; Chaturvedi AK
    J Natl Cancer Inst; 2013 Dec; 105(24):1871-80. PubMed ID: 24249745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anthropometry, body fat composition and reproductive factors and risk of oesophageal and gastric cancer by subtype and subsite in the UK Biobank cohort.
    Sanikini H; Muller DC; Chadeau-Hyam M; Murphy N; Gunter MJ; Cross AJ
    PLoS One; 2020; 15(10):e0240413. PubMed ID: 33079929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective cohort study of obesity and risk of oesophageal and gastric adenocarcinoma in the NIH-AARP Diet and Health Study.
    O'Doherty MG; Freedman ND; Hollenbeck AR; Schatzkin A; Abnet CC
    Gut; 2012 Sep; 61(9):1261-8. PubMed ID: 22174193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating Sex Hormone Levels and Risk of Esophageal Adenocarcinoma in a Prospective Study in Men.
    Xie SH; Ness-Jensen E; Rabbani S; Langseth H; Gislefoss RE; Mattsson F; Lagergren J
    Am J Gastroenterol; 2020 Feb; 115(2):216-223. PubMed ID: 31658123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obesity and Oesophageal Cancer.
    Nimptsch K; Steffen A; Pischon T
    Recent Results Cancer Res; 2016; 208():67-80. PubMed ID: 27909902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-hodgkin lymphoma and circulating markers of inflammation and adiposity in a nested case-control study: the multiethnic cohort.
    Conroy SM; Maskarinec G; Morimoto Y; Franke AA; Cooney RV; Wilkens LR; Goodman MT; Hernadez BY; Le Marchand L; Henderson BE; Kolonel LN
    Cancer Epidemiol Biomarkers Prev; 2013 Mar; 22(3):337-47. PubMed ID: 23300021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adiposity and risk of oesophageal cancer subtypes in the Million Women Study.
    Sweetland S; Floud S; Gaitskell K; Reeves GK;
    Int J Epidemiol; 2023 Dec; 52(6):1795-1804. PubMed ID: 37437897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the prognostic value of tumour- and patient-related factors in patients undergoing potentially curative resection of oesophageal cancer.
    Dutta S; Crumley AB; Fullarton GM; Horgan PG; McMillan DC
    World J Surg; 2011 Aug; 35(8):1861-6. PubMed ID: 21538187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diet-related inflammation and oesophageal cancer by histological type: a nationwide case-control study in Sweden.
    Lu Y; Shivappa N; Lin Y; Lagergren J; Hébert JR
    Eur J Nutr; 2016 Jun; 55(4):1683-94. PubMed ID: 26189130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammatory Markers and Risk of Epithelial Ovarian Cancer by Tumor Subtypes: The EPIC Cohort.
    Ose J; Schock H; Tjønneland A; Hansen L; Overvad K; Dossus L; Clavel-Chapelon F; Baglietto L; Boeing H; Trichopolou A; Benetou V; Lagiou P; Masala G; Tagliabue G; Tumino R; Sacerdote C; Mattiello A; Bueno-de-Mesquita HB; Peeters PH; Onland-Moret NC; Weiderpass E; Gram IT; Sánchez S; Obon-Santacana M; Sànchez-Pérez MJ; Larrañaga N; Castaño JM; Ardanaz E; Brändstedt J; Lundin E; Idahl A; Travis RC; Khaw KT; Rinaldi S; Romieu I; Merritt MA; Gunter MJ; Riboli E; Kaaks R; Fortner RT
    Cancer Epidemiol Biomarkers Prev; 2015 Jun; 24(6):951-61. PubMed ID: 25855626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating adiponectin and resistin levels in relation to metabolic factors, inflammatory markers, and vascular reactivity in diabetic patients and subjects at risk for diabetes.
    Shetty GK; Economides PA; Horton ES; Mantzoros CS; Veves A
    Diabetes Care; 2004 Oct; 27(10):2450-7. PubMed ID: 15451915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating Inflammation Markers, Risk of Lung Cancer, and Utility for Risk Stratification.
    Shiels MS; Katki HA; Hildesheim A; Pfeiffer RM; Engels EA; Williams M; Kemp TJ; Caporaso NE; Pinto LA; Chaturvedi AK
    J Natl Cancer Inst; 2015 Oct; 107(10):. PubMed ID: 26220734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediagnostic serum levels of inflammatory biomarkers are correlated with future development of lung and esophageal cancer.
    Keeley BR; Islami F; Pourshams A; Poustchi H; Pak JS; Brennan P; Khademi H; Genden EM; Abnet CC; Dawsey SM; Boffetta P; Malekzadeh R; Sikora AG
    Cancer Sci; 2014 Sep; 105(9):1205-11. PubMed ID: 25040886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating Adipokines and Inflammatory Markers and Postmenopausal Breast Cancer Risk.
    Gunter MJ; Wang T; Cushman M; Xue X; Wassertheil-Smoller S; Strickler HD; Rohan TE; Manson JE; McTiernan A; Kaplan RC; Scherer PE; Chlebowski RT; Snetselaar L; Wang D; Ho GY
    J Natl Cancer Inst; 2015 Sep; 107(9):. PubMed ID: 26185195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cigarette smoking and variations in systemic immune and inflammation markers.
    Shiels MS; Katki HA; Freedman ND; Purdue MP; Wentzensen N; Trabert B; Kitahara CM; Furr M; Li Y; Kemp TJ; Goedert JJ; Chang CM; Engels EA; Caporaso NE; Pinto LA; Hildesheim A; Chaturvedi AK
    J Natl Cancer Inst; 2014 Nov; 106(11):. PubMed ID: 25274579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective study of immune and inflammation markers and risk of lung cancer among female never smokers in Shanghai.
    Shiels MS; Shu XO; Chaturvedi AK; Gao YT; Xiang YB; Cai Q; Hu W; Shelton G; Ji BT; Pinto LA; Kemp TJ; Rothman N; Zheng W; Hildesheim A; Lan Q
    Carcinogenesis; 2017 Oct; 38(10):1004-1010. PubMed ID: 28981818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased levels of circulating interleukin 6, interleukin 8, C-reactive protein, and risk of lung cancer.
    Pine SR; Mechanic LE; Enewold L; Chaturvedi AK; Katki HA; Zheng YL; Bowman ED; Engels EA; Caporaso NE; Harris CC
    J Natl Cancer Inst; 2011 Jul; 103(14):1112-22. PubMed ID: 21685357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The epidemic of oesophageal carcinoma: Where are we now?
    Thrift AP
    Cancer Epidemiol; 2016 Apr; 41():88-95. PubMed ID: 26851752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral disease and risk of oesophageal and gastric cancer in a nationwide nested case-control study in Sweden.
    Ljung R; Martin L; Lagergren J
    Eur J Cancer; 2011 Sep; 47(14):2128-32. PubMed ID: 21489778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.